Cargando…

Mo1358: IMPACT OF SARS-COV-2 INFECTION ON RECIPIENTS OF LIVER TRANSPLANT. REPORT OF A MEXICAN COHORT.

Detalles Bibliográficos
Autores principales:	Azamar-Llamas, Daniel, Arenas-Martinez, Josealberto S., Cedillo, Maria F. Garcia, Ávila-Rojo, Esmeralda, Fernandez-Ramirez, Alfonso J., Kauffman-Ortega, Eric, Ruiz-Manríquez, Jesús Alejandro, Marquez-Guillén, Ernesto, Flores-García, Nayelli C., Rodriguez-Aguilar, Erika F., Vilatobá, Mario, López-Yáñez, Maria S., Garcia-Juarez, Ignacio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AGA Institute. Published by Elsevier Inc. 2022
Materias:	AGA Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212615/ http://dx.doi.org/10.1016/S0016-5085(22)61780-3

Ejemplares similares

Fr015 FACTORS RELATED TO NEW ONSET DYSPEPSIA AFTER COVID 19 INFECTION IN MEXICAN POPULATION
por: Rendon, Ricardo Flores, et al.
Publicado: (2021)

Mo1021: THE EFFECT OF HIDDEN CELIAC DISEASE ON COVID-19 IN THE COMMUNITY
por: Choung, Rok Seon, et al.
Publicado: (2022)

Mo1087: MALADAPTIVE BEHAVIORS IN PERSONS WITH IBD DURING THE COVID-19 PANDEMIC
por: Shaffer, Seth R., et al.
Publicado: (2022)

Mo1000: DISPARITIES IN HEALTHCARE UTILIZATION BEFORE, DURING, AND AFTER THE COVID-19 PANDEMIC LOCKDOWN
por: Sanaka, Harsha, et al.
Publicado: (2022)

Mo1074: FELLOW EXPERIENCES WITH ENDOSCOPY SIMULATION BEFORE AND DURING THE COVID-19 PANDEMIC: AN INTERNATIONAL SURVEY
por: Lee, Briton, et al.
Publicado: (2022)

Mo1055: COST-EFFECTIVENESS ANALYSIS OF SUBCUTANEOUS INFLIXIMAB FOR INFLAMMATORY BOWEL DISEASES IN SEQUENCIAL BIOLOGICAL TREATMENT
por: Baik, Deborah, et al.
Publicado: (2022)

Mo1020: GUT MICROBIOME CHANGES ASSOCIATED WITH HIGHER AND LONGER-LASTING ANTIBODY TITERS FOLLOWING COVID-19 VACCINATION
por: Venzon, Mericien M., et al.
Publicado: (2022)

Mo1623: FOODS OR FADS? OUTCOMES OF KETOGENIC, PLANT-BASED, AND INTERMITTENT FASTING DIETS: A SYSTEMATIC REVIEW AND METAANALYSIS
por: Srinivasan, Sachin, et al.
Publicado: (2022)

Mo1054: DIAGNOSTIC STRATEGIES FOR HELICOBACTER PYLORI IN PATIENTS WITH BLEEDING PEPTIC ULCERS UNDERGOING ENDOSCOPY: A COST-EFFECTIVENESS ANALYSIS
por: Artin, Michael G., et al.
Publicado: (2022)

Mo1086: MENTAL HEALTH IN IBD DURING THE COVID-19 PANDEMIC: ACCESS TO MENTAL HEALTH CARE AND EXPOSURE TO PANDEMIC NEWS
por: Shaffer, Seth R., et al.
Publicado: (2022)

Mo1019: THE IMPACT OF IBS ON SELF-REPORTED PHYSICAL AND MENTAL HEALTH DURING THE COVID PANDEMIC – A NORWEGIAN TWIN STUDY
por: Kutschke, Julia, et al.
Publicado: (2022)

Mo1088: DIFFERENCES BETWEEN FUNCTIONAL CONSTIIPATION AND CONSTIPATION-PREDOMNANT IRRITABLE BOWEL SYNDROME WITH FOCUS PERFERCTIONISM BY STATISTICAL FACTOR ANALYSIS
por: Yamamoto, Sayuri, et al.
Publicado: (2022)

Mo1621: DISTINCT PHENOTYPES OF MULTI-ORGAN ABNORMALITIES IN LONG COVID AND TYPE 2 DIABETES IDENTIFIED BY MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING
por: Eichert, Nicole, et al.
Publicado: (2022)

Mo1622: EFFICACY OF GLP-1 ANALOGS AND AGONISTS ON PROPORTION OF WEIGHT LOSS IN OVERWEIGHT OR OBESE DIABETICS AND NONDIABETICS: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Vosoughi, Kia, et al.
Publicado: (2022)

Mo1620: ECTOPIC FAT DEPOSITION IN THE LIVER AND PANCREAS AND THE PRESENCE OF EXCESS VISCERAL ADIPOSE TISSUE SIGNIFICANTLY INCREASE HOSPITALISATION RISK FOLLOWING COVID-19.
por: Waddell, Tom H., et al.
Publicado: (2022)

Mo1423: PATIENT PERSPECTIVES ON REMOTE HYPNOTHERAPY FOR IRRITABLE BOWEL SYNDROME DURING THE COVID-19 PANDEMIC: THE 'NEW NORM’ OR JUST A TEMPORARY SOLUTION?
por: Noble, Hithin, et al.
Publicado: (2022)

Mo1018: THE T-CELL RESPONSE TO SARS-COV-2 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IS OFTEN DEFICIENT IN ANTIBODY-RESPONDERS, AND AUGMENTED BY ANTI-TNF THERAPY
por: Li, Dalin, et al.
Publicado: (2022)

Su1496: SARS-COV-2 INFECTION IN IBD: PANDEMIC WAVES AND PREDICTORS OF SEVERE OR PERSISTENT COVID-19
por: Taxonera, Carlos, et al.
Publicado: (2022)

Sa114 PREVALENCE OF COVID-19 AMONG OUTPATIENTS PRESENTING FOR NON-URGENT ENDOSCOPY IN A LARGE HEALTHCARE NETWORK
por: Soroudi, Camille, et al.
Publicado: (2021)

Fr137 FIRST HIGH DIMENSIONAL EXAMINATION OF INTESTINAL BIOPSIES IN PATIENTS WITH COVID-19
por: Jha, Divya, et al.
Publicado: (2021)

Sa1275: ASSOCIATED FACTORS WITH ACUTE DIARRHEA IN SARS-COV-2 INFECTION: A CASE-CONTROL STUDY
por: Tellez, Francisco A. Felix, et al.
Publicado: (2022)

787 TIVURON PROJECT: AN INTERNATIONAL MULTICENTER PROSPECTIVE COHORT STUDY EVALUATING THE GASTROINTESTINAL SYMPTOMS AND COMPLICATIONS OF COVID-19 IN HOSPITALIZED PATIENTS
por: Sánchez-Luna, Sergio A., et al.
Publicado: (2021)

Su1501: PROPHYLACTIC VERSUS ENDOSCOPY DRIVEN TREATMENT OF CROHN'S POSTOPERATIVE RECURRENCE: A RETROSPECTIVE MULTICENTRIC EUROPEAN STUDY
por: Geldof, Jeroen, et al.
Publicado: (2022)

Sa1271: PATIENTS WITH CELIAC DISEASE HAVE NO INCREASED RATE OF ADVERSE EVENTS AFTER COVID-19 VACCINE ADMINISTRATION COMPARED WITH NON-CELIAC CONTROLS
por: Russell, Lindsey, et al.
Publicado: (2022)

Su1076: DIVERTICULOSIS IS ASSOCIATED WITH INTERNAL HEMORRHOIDS ON COLONOSCOPY: POSSIBLE CLUES TO ETIOLOGY.
por: Sninsky, Jared A., et al.
Publicado: (2022)

Sa1421: HOSPITALIZATIONS FOR ALCOHOLIC LIVER DISEASE DURING THE COVID-19 PANDEMIC INCREASED MORE FOR WOMEN, ESPECIALLY YOUNG WOMEN, COMPARED TO MEN.
por: Campbell, John P., et al.
Publicado: (2022)

Su102 DIFFERENCES IN INTESTINAL EPITHELIAL GENE EXPRESSION MODULATES SARS-COV-2 INFECTION IN HUMAN IBD ENTEROIDS
por: Alvarado, David M., et al.
Publicado: (2021)

Tu1544: HUMORAL AND T CELL RESPONSES TO COVID-19 VACCINATION IN INFLAMMATORY BOWEL DISEASE
por: Zhang, Eva, et al.
Publicado: (2022)

Su095 REAL-TIME DEFORMABILITY CYTOMETRY (RT-DC) REVEALS NOVEL CORRELATIONS BETWEEN INFLAMMATION AND MECHANICAL PROPERTIES OF NEUTROPHILS IN IBD PATIENTS
por: Ganzleben, Ingo, et al.
Publicado: (2021)

Fr017 A MULTICENTER CASE SERIES OF COVID-19 INDUCED ACUTE PANCREATITIS AT 4 ACADEMIC CENTERS IN NEW YORK CITY
por: Ali, Yasir, et al.
Publicado: (2021)

1156: A COMPARISON BETWEEN REAL WORLD WEIGHT LOSS OUTCOMES WITH ANTI-OBESITY MEDICATIONS BEFORE AND DURING COVID-19 PANDEMIC
por: Rosa, Alan De la, et al.
Publicado: (2022)

Tu1551: PATIENTS WITH INFLAMMATORY BOWEL DISEASES HAVE IMPAIRED ANTIBODY PRODUCTION AFTER ANTI-SARS-COV-2 VACCINATION, ESPECIALLY THOSE ON ANTI-TNFα OR COMBINATION TREATMENT OF BIOLOGICS PLUS IMMUNOMODULATORS: RESULTS FROM A PANHELLENIC REGISTRY
por: Zacharopoulou, Eirini, et al.
Publicado: (2022)

Sa1318: IMPACT OF OBESITY ON OUTCOMES ASSOCIATED WITH ACUTE ALCOHOLIC PANCREATITIS
por: Pellegrini, James R., et al.
Publicado: (2022)

Su093 GUT-BRAIN AXIS AND IRRITABLE BOWEL SYNDROME DURING SARS COV-2 PANDEMIC. A SURVEY BASED STUDY.
por: Piskorz, Maria, et al.
Publicado: (2021)

651: SARS-COV-2 IS DETECTED IN THE GASTROINTESTINAL TRACT OF ASYMPTOMATIC OUTPATIENTS USING ROUTINE ENDOSCOPY BUT POSES MINIMAL TRANSMISSION RISK
por: Gentry, Andrew B., et al.
Publicado: (2022)

18 COVID-19 AND THE GUT IN HUMAN OBESITY: OVEREXPRESSION OF SARS-COV-2 RECEPTORS REVEALED BY DEEP SINGLE CELL RNA-SEQ
por: Mcrae, Alison, et al.
Publicado: (2021)

EP1272: DIETARY LIPIDS FUEL METABOLIC ENTERITIS IN CROHN'S DISEASE
por: Schwärzler, Julian, et al.
Publicado: (2022)

Su1189 SAFETY OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH PREEXISTING INFLAMMATORY BOWEL DISEASE AND MICROSCOPIC COLITIS
por: Grover, Shilpa, et al.
Publicado: (2020)

Sa127 AN IBD-RISK VARIANT IN PTPN2 PROMOTES CELLULAR UPTAKE OF SARS-COV-2, WHICH IS MITIGATED BY THE JAK INHIBITOR TOFACITINIB
por: Spalinger, Marianne, et al.
Publicado: (2021)

Fr005 SEVERE COVID-19 ASSOCIATED WITH INCREASED RISK OF GI BLEEDING DURING HOSPITALIZATION
por: Alvencar, Sujay, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qcbjrjqn2usqt6335iic14l4vo